ACTRIMS Action Center
Explore the forefront of multiple sclerosis research with the ACTRIMS Action Center. Here you’ll find leading experts in the field share insights on the latest studies, innovative treatment approaches, and evolving patient management strategies that emerged from the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum.
Episodes 1-15 of 15
Engineering Autoimmunity: A New Model for Studying MS Progression and Remyelination
NeuroFrontiersEngineering Autoimmunity: A New Model for Studying MS Progression and Remyelination
Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
NeuroFrontiersSafety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
NeuroFrontiersMS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
NeuroFrontiersUnderstanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
NeuroFrontiersEmerging Technologies in MS: Neuromodulation and Myelin Regeneration
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
NeuroFrontiersMS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
Advancements in Multiple Sclerosis: Insights from the 2024 ACTRIMS Forum
NeuroFrontiersAdvancements in Multiple Sclerosis: Insights from the 2024 ACTRIMS Forum
Exploring the Latest in MS Cognitive Rehabilitation Strategies
NeuroFrontiersExploring the Latest in MS Cognitive Rehabilitation Strategies
Visionary Insights: Assessing MS-Related Retinal Changes with Adaptive Optics
NeuroFrontiersVisionary Insights: Assessing MS-Related Retinal Changes with Adaptive Optics
Unmet Needs in Rehabilitation Research for Multiple Sclerosis
NeuroFrontiersUnmet Needs in Rehabilitation Research for Multiple Sclerosis
MS Research: Using Epigenetic Clocks and Biomarkers to Assess Biological Aging
NeuroFrontiersMS Research: Using Epigenetic Clocks and Biomarkers to Assess Biological Aging
Telehealth in MS Care: Addressing the Potential for Improvement and Concerns
NeuroFrontiersTelehealth in MS Care: Addressing the Potential for Improvement and Concerns
Addressing Healthcare Barriers in Patients with Multiple Sclerosis
NeuroFrontiersAddressing Healthcare Barriers in Patients with Multiple Sclerosis
New Study Shows EBV-Specific T-Cells Contribute to MS Development
NeuroFrontiersNew Study Shows EBV-Specific T-Cells Contribute to MS Development
Investigating the Clinical Utility of the Multiple Sclerosis Disease Activity Test
NeuroFrontiersInvestigating the Clinical Utility of the Multiple Sclerosis Disease Activity Test
